3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
6
Phase 2
5
Phase 1
5
Phase 3
1
Phase 2/3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
31
Rectal Neoplasms
29
Neoplasm Metastasis
15
Stomach Neoplasms
12
Pancreatic Neoplasms
11
Small Cell Lung Carcinoma
7
Esophageal Squamous Cell Carcinoma
7
Neoplasms
6
Esophageal Neoplasms
6
Rhabdomyosarcoma
4
Intestinal Neoplasms
4
Gastrointestinal Neoplasms
4
Digestive System Neoplasms
4
Uterine Cervical Neoplasms
3
Sarcoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Rectal Diseases
2
Neuroblastoma
2
Neoplasms by Histologic Type
2
Intestinal Diseases
2
Hepatoblastoma
2
Gastrointestinal Diseases
2
Ganglioneuroblastoma
2
Digestive System Diseases
2
Colorectal Cancer Metastatic
2
Colorectal Adenocarcinoma
2
Colonic Diseases
2
Interventions
Vincristine
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
Busulfan
2
treosulfan
1
ganitumab
1
etoposide phosphate
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Temozolomide
1
Radiosurgery
1
Radiation
1
Melphalan
1
Irinotecan
1
FANG vaccine
1
Diphosphonates
1
Dactinomycin
1
Cyproheptadine
1
Congresses as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma, Ewing
×
Irinotecan
×
Clear all
NCT03495921
2023-04-26
VITA
Gradalis, Inc.
Phase 3
Terminated
32 enrolled
13 charts